Figure S4 from TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer
Tiara T. Byrd,Kristen Fousek,Antonella Pignata, Christopher Szot, Heba Samaha,Steven Seaman,Lacey Dobrolecki,Vita S. Salsman,Htoo Zarni Oo,Kevin Bielamowicz,Daniel Landi, Nino Rainusso,John Hicks,Suzanne Powell,Matthew L. Baker,Winfried S. Wels,Joachim Koch,Poul H. Sorensen,Benjamin Deneen,Matthew J. Ellis,Michael T. Lewis,Meenakshi Hegde,Bradley S. Fletcher,Brad St. Croix,Nabil Ahmed crossref（2023）
摘要
L2 CAR T cells provide a survival advantage and disrupt vessels and tumor architecture in TNBC xenografts .
查看译文
AI 理解论文
溯源树
样例
